Initiation of Home Mechanical Ventilation at Home in a Selectve Group of Patients With Chronic Hypercapnic Respiratory Failure in the Netherlands
| Registry | NCT03203577, acronym Homerun |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 96 (Actual) |
| Sponsor | University Medical Center Groningen (Other) |
| Conditions | Respiratory Therapy, Respiration, Artificial, Positive-Pressure Respiration, Neuromuscular Diseases, Noninvasive Ventilation, Cost-Benefit Analysis, Ambulatory Monitoring |
| Interventions | Initiation of mechanical ventilation (Procedure) |
| Dates | start 2015-07-01, primary completion 2017-12-01, completion 2018-05-01, first posted 2017-06-29, last updated 2018-06-18 |
| Locations | 1 site in Netherlands |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Respiratory Therapy All trials for Respiration, Artificial All trials of Initiation of mechanical ventilation
Objective: To prove that initiation of chronic ventilatory support at home, in patients with chronic hypercapnic respiratory failure due to neuromuscular disease (NMD) or thoracic cage problem is not inferior compared to initiation in a hospital based setting. In addition we believe that the start at home is cheaper compared to an in-hospital start.
Hypothesis: Initiation of chronic ventilatory support at home is effective, safe and cost effective compared to a hospital-based initiation.
Study design: A nationwide non-inferiority multi-center randomized parallel active control study.
Study population: Patients with chronic respiratory insufficiency due to a neuromuscular disease (NMD) or thoracic cage problem who are referred for chronic ventilator support.
Intervention: The start of HMV at home Standard intervention to be compared to: The start of HMV is normally in a clinical setting as recommended in the national guideline.
Outcome measures: Primary: PaCO2. Secondary: Health related quality of life; lung function; nocturnal transcutaneous carbon dioxide assessment and saturation, and costs Sample size calculation/data analysis: This is a non-inferiority trial based on PaCO2 as primary outcome. A difference in favor of the hospital care group of smaller than 0.5 kPa will be labeled as non-inferior. To retain 72 evaluable patients, and allow for drop-outs, we will include 96 patients in total.
Cost-effectiveness analysis: A cost analysis will be conducted alongside the clinical trial. Costs of the initiation of HMV at home and in the hospital will be estimated form a societal perspective over a time horizon of 6 months.
Time schedule: After an initial phase of 6 months recruitment will start and will take 24 months. Thirty-six months after the start of the study the last assessments will be done and analysis and writing of the papers will start. After 42 months the study will end.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Hospital initiation | Active comparator | Procedure: Initiation of mechanical ventilation | Initiation of mechanical ventilation in hospital initiation of Home Mechanical ventilation takes place in a hospital; this makes this arm the standard care. |
| Home initiation | Experimental | Procedure: Initiation of mechanical ventilation | Initiation of mechanical ventilation at home Initiation of mechanical ventilation in a patient's home setting with telemonitoring |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * Indication to initiate non-invasive ventilatory support in patients with a neuromuscular disease or thoracic cage abnormality who suffer from complaints of alveolar hypoventilation (fatigue, headache of dyspnoea) combined with all following elements: * arterial carbon dioxide > 6.0 kPa daytime or arterial or transcutaneous carbon dioxide > 6.0 kPa at night or orthopnea as a result of diaphragm paralysis * Age > 18 years * Existence, of a sufficient network (social or professional) according to the supervising HMV center making initiation of HMV at home possible and safe. Exclusion Criteria: * Patients who already have had HMV due to acute respiratory failure * Necessity for invasive ventilatory support * Patients admitted to a nursing home
| Facility | City | Country | Status |
|---|---|---|---|
| University Medical Center Groningen | Groningen | Netherlands |